BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 26118341)

  • 21. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular Vesicle-Mediated Communication between the Glioblastoma and Its Microenvironment.
    Matarredona ER; Pastor AM
    Cells; 2019 Dec; 9(1):. PubMed ID: 31906023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.
    Nakano I; Garnier D; Minata M; Rak J
    Semin Cell Dev Biol; 2015 Apr; 40():17-26. PubMed ID: 25721810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping.
    Lane R; Simon T; Vintu M; Solkin B; Koch B; Stewart N; Benstead-Hume G; Pearl FMG; Critchley G; Stebbing J; Giamas G
    Commun Biol; 2019; 2():315. PubMed ID: 31453379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focus on Extracellular Vesicles: New Frontiers of Cell-to-Cell Communication in Cancer.
    Ciardiello C; Cavallini L; Spinelli C; Yang J; Reis-Sobreiro M; de Candia P; Minciacchi VR; Di Vizio D
    Int J Mol Sci; 2016 Feb; 17(2):175. PubMed ID: 26861306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy?
    Martellucci S; Orefice NS; Angelucci A; Luce A; Caraglia M; Zappavigna S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Extracellular Vesicles in Hematological Malignancies.
    Raimondo S; Corrado C; Raimondi L; De Leo G; Alessandro R
    Biomed Res Int; 2015; 2015():821613. PubMed ID: 26583135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs in extracellular vesicles: potential cancer biomarkers.
    Kinoshita T; Yip KW; Spence T; Liu FF
    J Hum Genet; 2017 Jan; 62(1):67-74. PubMed ID: 27383658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biogenesis and Functions of Exosomes and Extracellular Vesicles.
    Dreyer F; Baur A
    Methods Mol Biol; 2016; 1448():201-16. PubMed ID: 27317183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer.
    Godlewski J; Ferrer-Luna R; Rooj AK; Mineo M; Ricklefs F; Takeda YS; Nowicki MO; Salińska E; Nakano I; Lee H; Weissleder R; Beroukhim R; Chiocca EA; Bronisz A
    Stem Cell Reports; 2017 Jun; 8(6):1497-1505. PubMed ID: 28528698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging MS-based platforms for the characterization of tumor-derived exosomes isolated from human biofluids: challenges and promises of MudPIT.
    Ferrari E; De Palma A; Mauri P
    Expert Rev Proteomics; 2017 Sep; 14(9):757-767. PubMed ID: 28780902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer.
    Vaidya M; Sugaya K
    PLoS One; 2020; 15(2):e0229309. PubMed ID: 32092088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update.
    Whiteside TL
    Expert Rev Mol Diagn; 2018 Dec; 18(12):1029-1040. PubMed ID: 30406709
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker.
    Vaidya M; Bacchus M; Sugaya K
    PLoS One; 2018; 13(5):e0197782. PubMed ID: 29787607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosome-mediated communication in the ovarian follicle.
    Di Pietro C
    J Assist Reprod Genet; 2016 Mar; 33(3):303-311. PubMed ID: 26814471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma.
    Rackles E; Lopez PH; Falcon-Perez JM
    Semin Cancer Biol; 2022 Dec; 87():148-159. PubMed ID: 36375777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression.
    Czernek L; Düchler M
    Arch Immunol Ther Exp (Warsz); 2017 Aug; 65(4):311-323. PubMed ID: 28101591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vesiclemia: counting on extracellular vesicles for glioblastoma patients.
    Sabbagh Q; Andre-Gregoire G; Guevel L; Gavard J
    Oncogene; 2020 Sep; 39(38):6043-6052. PubMed ID: 32801336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis.
    Nag S; Bhattacharya B; Dutta S; Mandal D; Mukherjee S; Anand K; Eswaramoorthy R; Thorat N; Jha SK; Gorai S
    ACS Biomater Sci Eng; 2023 Sep; 9(9):5205-5221. PubMed ID: 37578350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of exosome release by extracellular DNA is conserved across multiple cell types.
    Iliev D; Strandskog G; Nepal A; Aspar A; Olsen R; Jørgensen J; Wolfson D; Ahluwalia BS; Handzhiyski J; Mironova R
    FEBS J; 2018 Aug; 285(16):3114-3133. PubMed ID: 29953723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.